
Our Injectables business supplies hospitals across our markets with generic injectables, supported by our manufacturing facilities in the US, Europe and MENA.
45% of Group revenue (2021: 41%)

Our Branded business supplies branded generics and in-licensed patented products from our local manufacturing facilities to retail and hospital customers across the MENA region.
27% of Group revenue (2021: 26%)

Our Generics business supplies oral and other
non‑injectable generic and specialty branded products in the US retail market, leveraging our
state-of-art manufacturing facility in Columbus, Ohio.
non‑injectable generic and specialty branded products in the US retail market, leveraging our
state-of-art manufacturing facility in Columbus, Ohio.
27% of Group revenue (2021: 32%)